Kazunori Omote

Dr. Kazunori Omote

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2023 in Circulation Journal
Verified
Journal Article
Open access
PDF file
KOKazunori Omote
Kazunori Omote
BBBarry A. Borlaug
Barry A. Borlaug
The left atrium (LA) plays an important role in facilitating left ventricular (LV) filling by acting as a reservoir, passive conduit, and active booster pump, as well as a regulator of blood volume through A-type natriuretic peptide secretion in response to stimulation by mechanical stretch of the cavity. LA myopathy has emerged as one of the most important non-LV contributors to disease progression in heart failure with preserved ejection fraction (HFpEF). LA dysfunction is common in HFpEF and is associated with more severe pulmonary vascular disease and right ventricular dysfunction, and increases the risk of incident atrial fibrillation or atrial functional mitral regurgitation, leading to limitations in cardiac output reserve and reduced exercise capacity. LA deformation assessed by 2-dimensional speckle-tracking echocardiography is useful for estimating abnormal hemodynamics or exercise capacity, discriminating HFpEF from non-cardiac dyspnea and is an independent predictor of adverse outcome in HFpEF. Thus, interventions directly targeting LA myopathy may improve outcomes in HFpEF with LA myopathy. This review provides information regarding the physiology of the LA in patients with HFpEF and discusses the importance of evaluation of LA function, management issues, and future directions through ongoing trials of medical interventions.

7 November 2020 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
THTomonari Harada
Tomonari Harada
MOMasaru Obokata
Masaru Obokata
KOKazunori Omote
Kazunori Omote
HIHiroyuki Iwano
Hiroyuki Iwano
TITakahiro Ikoma
Takahiro Ikoma
MKMasahiko Kurabayashi
Masahiko Kurabayashi
This study sought to determine the independent and incremental prognostic value of semiquantitative measures of tricuspid regurgitation (TR) severity over right heart remodelling and pulmonary hypertension (PH) in heart failure with preserved ejection fraction (HFpEF). Echocardiography was performed on 311 HFpEF patients. TR severity was defined by the semiquantitative measures [i.e. vena contracta width (VCW) and jet area] and by the guideline-based integrated qualitative approach (absent, mild, moderate, or severe). All-cause mortality or heart failure hospitalization occurred in 101 patients over a 2.1-year median follow-up. There was a continuous association between TR severity and the composite outcome with a hazard ratio (HR) of 1.17 per 1 mm increase of VCW [95% confidence interval (CI) 1.08–1.26, P < 0.0001]. Compared with patients with the lowest VCW category (≤1 mm), RV-adjusted HRs for the outcome were 1.99 (95% CI 1.05–3.77), 2.63 (95% CI 1.16–5.95), and 5.00 (95% CI 1.60–15.7) for 1–3, 3–7, and ≥7 mm VCW categories, respectively. TR severity as defined by the guideline-based approach showed a similarly graded association, but it was no longer significant in models including PH. In contrast, VCW remained independently and incrementally associated with the outcome after adjusting for established prognostic factors, as well as RV diameter and PH (fully adjusted HR 1.14 per 1 mm, 95% CI 1.02–1.27, P = 0.02; χ2 58.8 vs. 51.5, P = 0.03). The current data highlight the potential value of the semiquantitative measures of TR severity for the risk stratification in patients with HFpEF.

1 March 2023 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
STSakae Takenaka
Sakae Takenaka
TSTakuma Sato
Takuma Sato
TNToshiyuki Nagai
Toshiyuki Nagai
KOKazunori Omote
Kazunori Omote
YKYuta Kobayashi
Yuta Kobayashi
TAToshihisa Anzai
Toshihisa Anzai
The change in right ventricular stroke work index (RVSWI) during exercise, not RVSWI at rest, was associated with exercise capacity and HRQoL. Our findings suggest that the assessment of change in RVSWI during exercise as a surrogate of RV reserve function may aid in risk stratification of patients with LVAD.

31 July 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
FNFunayama Naohiro
Funayama Naohiro
RIRyosuke Ito
Ryosuke Ito
YIYuki Ishidoya
Yuki Ishidoya
KOKazunori Omote
Kazunori Omote
DSDaisuke Sunaga
Daisuke Sunaga

5 August 2025 in Journal of Nuclear Cardiology
Verified
Journal Article
Open access
TATomohi Ajima
Tomohi Ajima
TATadao Aikawa
Tadao Aikawa
TSToshinori Saitou
Toshinori Saitou
YMYuya Matsue
Yuya Matsue
SFShinichiro Fujimoto
Shinichiro Fujimoto
TMTohru Minamino
Tohru Minamino

1 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KNKosuke Nakamura
Kosuke Nakamura
SISuguru Ishizaka
Suguru Ishizaka
KOKazunori Omote
Kazunori Omote
YYYutaro Yasui
Yutaro Yasui
YMYoshifumi Mizuguchi
Yoshifumi Mizuguchi
TAToshihisa Anzai
Toshihisa Anzai
Aim: The present study aimed to investigate the impact of mild tricuspid regurgitation (TR) on the exercise capacity or clinical outcomes in patients with chronic heart failure (CHF). Methods and Results: The study enrolled 511 patients with CHF who underwent cardiopulmonary exercise testing (CPET) between 2013 and 2018. The primary outcome was a composite of heart failure hospitalization and death. Patients with mild TR (n = 324) or significant TR (moderate or greater; n = 60) displayed worse NHYA class and reduced exercise capacity on CPET than those with non-TR (n = 127), but these were more severely impaired in patients with significant TR. A total of 90 patients experienced events over a median follow-up period of 3.3 (interquartile range 0.8–5.5) years. Patients with significant TR displayed a higher risk of events, while patients with mild TR had a 3.0-fold higher risk of events than patients with non-TR (hazard ratio (HR) 3.01; 95% confidence interval (CI), 1.50–6.07). Multivariate Cox regression analysis showed that, compared with non-TR, mild TR was associated with increased adverse events, even after adjustment for co-variates (HR 2.97; 95% CI, 1.35–6.55). Conclusions: TR severity was associated with worse symptoms, reduced exercise capacity, and poor clinical outcomes. Even patients with mild TR had worse clinical characteristics than those with non-TR.